ADLM Diagnostics Innovation and COVID Testing

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

ADLM Diagnostics Innovation and COVID Testing

Sector: Diagnostics
Topic: Bio Break
YouTube video thumbnail

In this Bio Break episode, Nick Allan and Nigel Syrotuck reflect on recent ADLM diagnostics innovation and how it has shaped the future of clinical testing. The Association for Diagnostics & Laboratory Medicine (ADLM) recently wrapped its annual showcase in Chicago, and as always, it left a strong impression on the medtech community.

While discussing highlights from the show, Nick and Nigel zero in on a perfect case study of ADLM diagnostics innovation: the evolution of COVID-19 testing. From the early days of enzyme-linked immunosorbent assays (ELISAs) to the familiar lateral flow tests we now perform at home, diagnostics have become faster, simpler, and more accessible. This transformation—from complex lab environments to point-of-care and even bathroom-counter diagnostics—was on full display at ADLM.

From the Lab to the Bathroom Counter

As Nick points out, one of the most remarkable shifts in diagnostics is how complicated procedures have been distilled into everyday routines. What once required trained technicians in controlled environments can now be done at home, often with little more than a test strip and a timer. The lateral flow transformation is a clear example of how ADLM’s influence and technology leadership help shape the direction of consumer-friendly diagnostics.

Gloved technician handling sterile packaged medical instruments prepared for radiation sterilization validation.

Most sterile medical devices begin their journey long before anyone thinks about sterilization. Teams focus on function, usability, materials, and suppliers, then discover that sterilization constraints can reshape many of those early decisions.

Engineer sketching early medical device concepts on a whiteboard during initial design exploration.

After years of working with founders and technical teams, I have learned that early design missteps rarely come from engineering flaws. More often than not, they come from missing conversations.

AI dashboard and digital checklist displayed on a laptop as a MedTech founder reviews workflow automation.

Medtech founders operate with more constraints than most sectors. You are responsible for deep technical problem solving, high-stakes decisions, regulatory navigation, investor conversations, and a constant stream of operational tasks.

Grocery store aisle with red arrows highlighting items that reveal hidden health data, illustrating how consumer shopping behavior can signal medical information.

Consumer health prediction shapes more of daily life than most people realize. In this episode of Bio Break, Nick and Nigel explore how retail data can reveal health information without a person ever speaking to a clinician.